Josh Travers

Postdoctoral Fellow in the Division of Cardiology at the University of Colorado Anschutz Medical Campus

[Josh Travers @JoshTravers89]

It’s good to test your non-science skills every once in a while too. Happy to report the new upstairs floors are officially installed!

[Josh Travers @JoshTravers89]

Had a great time at the @universityofky Saha Cardiovascular Research Center Research Day and very honored to have received the Gill Heart and Vascular Institute Early Contributions to Cardiovascular Research Award @GillKentucky

[Josh Travers @JoshTravers89]

Welcome Ava! So happy for you to join our family

[Josh Travers @JoshTravers89]

#Paris2024 @katieledecky biggest fans

[Josh Travers @JoshTravers89]

@DrPorman You got this!

[McKinsey Lab @McKinseyLab]

Congratulations @Robinson7L for winning the @ISHR_NAS Young Investigator Competition Award AND the Litsa G Kranias Leadership Award! Well deserved! Two years in a row for an @McKinseyLab member to win the YICA (@JoshTravers89 in 2022).  Join our team to continue the tradition!

[Josh Travers @JoshTravers89]

@glynnis_garry @BWFUND @Transactivator Congrats! Well deserved

[Josh Travers @JoshTravers89]

I'm delighted to share the Notice of Award for my K99 to further explore HDAC inhibition in diastolic dysfunction and HFpEF. Very grateful for the support from my advisory committee, @McKinseyLab, @CUAnschutz Division of Cardiology and @nih_nhlbi.

[Circulation Research @CircRes]

1/5 New @CircRes podcast #DiscoverCircRes (https://t.co/9Tdy6bk9b5)! @StHilaireLab chats with @McKinseyLab from @CUCardiology about their study Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart https://t.co/i6rv57n1hO

[Circulation Research @CircRes]

Rubino et al found that high-throughput #phenotypic screening with #fibroblasts yields a new molecular pathway for #fibrosis. Learn more about chemical screens for drug discovery for #HeartDisease at https://t.co/qgrfa4rOmV
@McKinseyLab @JoshTravers89 @CUCardiology

[McKinsey Lab @McKinseyLab]

The @McKinseyLab has openings for motivated trainees to tackle how reversible PTMs regulate signaling and epigenetic pathways in cardiovascular and metabolic disease.
We have a number of exciting projects which have the potential to launch many academic or industry careers.

[McKinsey Lab @McKinseyLab]

We appreciate the opportunity to contribute an article on cardiac fibrosis for the @jclinicalinvest exciting review series on New Therapeutic Targets in Cardiovascular Diseases! @JoshTravers89 @CUAnschutz https://t.co/4ZCSQbQFFI https://t.co/H3xVlpXFc2

[Josh Travers @JoshTravers89]

@lamc_14 @ScienceAdvances @Joseph_C_Wu @CUAnschutz @StanfordCVI @ShaneRZhao1 Great work!

[World Health Organization (WHO) @WHO]

Today is #WorldHeartDay ♥️!

Cardiovascular diseases including heart attacks and strokes are the leading cause of death globally, accounting for nearly 1⃣8⃣ million lives lost every year.

Protect your heart 🫀 by choosing a healthy lifestyle 🏃🍊🚭

👉 https://t.co/afDLfGN0mT

[Josh Travers @JoshTravers89]

@sara_wennersten Bahahhahaha

[Josh Travers @JoshTravers89]

@m_alexanian @McKinseyLab @saptarsi_haldar @dsrivastava_md Here's to many more productive collaborations in the future! Congrats again!

[Michael Alexanian @m_alexanian]

Our work “A transcriptional switch governs fibroblast activation in heart disease” previously on @biorxivpreprint is now online @Nature. A great team effort @GladstoneInst @dsrivastava_md and all the fantastic collaborators. A new thread /1 👇
https://t.co/leqLScOyLG

[KC Woulfe, PhD @dr_kcwoulfe]

I am looking for a motivated and enthusiastic research technician to join our lab and study how age and sex affects sarcomeric function in the heart❤️ https://t.co/mW43uu459P. Please RT☺️

[McKinsey Lab @McKinseyLab]

Super excited to see our paper now out in this week’s issue @CircAHA! Thanks again to all involved. @JoshTravers89
Check out the accompanying podcast and editorial. https://t.co/hM8OcXB2Yb
https://t.co/O5uR0fCHOO https://t.co/4ZCSQbz4h8